SF3B1 mutation accelerates cancer progression through alternative RNA splicing in various cancer types by activating the Akt and NF-κB pathway, MYC activation, inflammation pathway, and TGF-β signaling in several cancers. This evidence concerns the gene SF3B1 and cancer.